Affordable Access

Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.

Authors
Type
Published Article
Journal
The Journal of Heart and Lung Transplantation
1053-2498
Publisher
Elsevier
Publication Date
Volume
23
Issue
4
Pages
461–465
Identifiers
PMID: 15063406
Source
Medline
License
Unknown

Abstract

The pre-emptive anti-CMV approach is superior to prophylaxis in CMV-seropositive heart transplant recipients. Both ganciclovir and CMVIG are equally effective.

Statistics

Seen <100 times